Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women

NACompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

July 31, 1996

Primary Completion Date

December 31, 2002

Study Completion Date

February 28, 2009

Conditions
Osteoporosis
Interventions
DRUG

Klodronate and Kliogest

PROCEDURE

Placebo+ Kliogest

DRUG

Bonefos

All Listed Sponsors
lead

Kuopio University Hospital

OTHER

NCT00877097 - Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women | Biotech Hunter | Biotech Hunter